Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs:Highlights des ASCO-Meetings 2015
Standard
Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs:Highlights des ASCO-Meetings 2015. / Bußmann, L; Busch, C-J; Knecht, R.
in: HNO, Jahrgang 63, Nr. 9, 09.2015, S. 620-4.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Konferenzaufsatz in Fachzeitschrift › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs:Highlights des ASCO-Meetings 2015
AU - Bußmann, L
AU - Busch, C-J
AU - Knecht, R
PY - 2015/9
Y1 - 2015/9
N2 - This year also saw a great number of phase II and III studies presented at the ASCO Annual Meeting, in which new drugs (monoclonal antibodies, small molecules) were investigated as an alternative to or in combination with established mono- and polychemotherapy in patients with recurrences or distance metastases from head and neck squamous cell carcinoma (R/M-HNSCC). The studies now presented here describe the different concepts being applied to drug-based treatment of R/M-HNSCC and illustrate the variety of therapeutic approaches to treatment of recurrences and metastases.
AB - This year also saw a great number of phase II and III studies presented at the ASCO Annual Meeting, in which new drugs (monoclonal antibodies, small molecules) were investigated as an alternative to or in combination with established mono- and polychemotherapy in patients with recurrences or distance metastases from head and neck squamous cell carcinoma (R/M-HNSCC). The studies now presented here describe the different concepts being applied to drug-based treatment of R/M-HNSCC and illustrate the variety of therapeutic approaches to treatment of recurrences and metastases.
U2 - 10.1007/s00106-015-0055-0
DO - 10.1007/s00106-015-0055-0
M3 - Konferenzaufsatz in Fachzeitschrift
C2 - 26319430
VL - 63
SP - 620
EP - 624
JO - HNO
JF - HNO
SN - 0017-6192
IS - 9
ER -